Fig. 1
From: Prophylactic and therapeutic effects of EsV3 on atherosclerotic lesions in ApoE−/− mice
Comparison of lipid (serum TC, TG, LDL-C, HDL-C) levels among groups at week 4 and week 16 (n = 8). A, E. TC; B, F. TG; C, G. HDL-C; D, H. LDL-C. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control group. # p < 0.05, ## p < 0.01, ### p < 0.001 vs. model group. & p < 0.05, && p < 0.01, &&& p < 0.001 vs. atorvastatin. ^ p < 0.05 vs. P-EsV3 groups. For comparisons involving multiple groups, a one-way ANOVA was performed. A two-tailed unpaired t-test was performed to compare the P-EsV3-L group with the EsV3-L group